Search Results: keywords:"product hopping"

  • H. R. 9070 — To amend title 35, United States Code, to prohibit product hopping, and for other purposes.
    💰
    Status:Introduced in House
    Words:1,245

    H.R. 9070, known as the "Affordable Prescriptions for Patients Act of 2024," aims to amend Title 35 of the United States Code to make it harder for companies to engage in "product hopping," a strategy used to delay generic competition for pharmaceuticals. The bill allows the sponsor of an...

    Simple Explanation

    H.R. 9070 is a bill that plans to stop medicine companies from using tricks to keep their drugs more expensive for longer and adds a lot of money to help old people get healthcare through Medicare.

  • S. 150 — An Act To amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes.
    💰
    Status:Engrossed in Senate
    Words:1,182

    S. 150 aims to modify the Federal Trade Commission Act to stop product hopping. The bill introduces changes to patent laws concerning biological products, restricting the number of patents that can be asserted in infringement cases and specifying conditions under which courts...

    Simple Explanation

    S. 150 is like a rule that tries to stop companies from sneaking around with medicine products, and it also gives a lot of money to help make a health program called Medicare better.